Five Reasons Why Your Biotech Comparative Value Theory Is Wrong

Sometimes it seems so easy. Company X does the same thing as Company Y – and X’s market cap is a small fraction of Y’s. It’s just a matter of time before the market wakes up, collapses the spread, and rewards the smart people who figured it out early and put on the right trade.

Long X + short Y. How could it not work?

I can think of a few ways…

1) Biotech stocks are not savings bonds.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC